Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
In this paper, a bilayer-core osmotic pump tablet (OPT) which does not require laser drilling to form the drug delivery orifice is described. The bilayer-core consisted of two layers: (a) push layer and (b) drug layer, and was made with a modified upper tablet punch, which produced an indentation at the center of the drug layer surface. The indented tablets were coated by using a conventional pan-coating process. Although the bottom of the indentation could be coated, the side face of the indentation was scarcely sprayed by the coating solution and this part of the tablet remained at least partly uncoated leaving an aperture from which drug release could occur. Nifedipine was selected as the model drug. Sodium chloride was used as osmotic agent, polyvinylpyrrolidone as suspending agent and croscarmellose sodium as expanding agent. The indented core tablet was coated by ethyl cellulose as semipermeable membrane containing polyethylene glycol 400 for controlling the membrane permeability. The formulation of core tablet was optimized by orthogonal design and the release profiles of various formulations were evaluated by similarity factor (f(2)). It was found that the optimal OPT was able to deliver nifedipine at an approximate zero-order up to 24 h, independent on both release media and agitation rates. The preparation of bilayer-core OPT was simplified by coating the indented core tablet, by which sophisticated technology of the drug layer identification and laser drilling could be eliminated. It might be promising in the field of preparation of bilayer-core OPT.
Liu
Longxiao
L
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China. liulx@zju.edu.cn
Xu
Xiangning
X
D002121:Calcium Channel Blockers / Q000737:chemistry*; D002266:Carboxymethylcellulose Sodium / Q000737:chemistry; D002482:Cellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D005079:Excipients / Q000737:chemistry; D007700:Kinetics; D008567:Membranes, Artificial; D009543:Nifedipine / Q000737:chemistry*; D009995:Osmosis; D010539:Permeability; D011092:Polyethylene Glycols / Q000737:chemistry*; D011205:Povidone / Q000737:chemistry; D012965:Sodium Chloride / Q000737:chemistry; D012995:Solubility; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000379:methods*
D002121:Calcium Channel Blockers; D005079:Excipients; D008567:Membranes, Artificial; D013607:Tablets; D011092:Polyethylene Glycols; D012965:Sodium Chloride; C013517:ethyl cellulose; D002482:Cellulose; D011205:Povidone; D009543:Nifedipine; D002266:Carboxymethylcellulose Sodium